SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-20-036429
Filing Date
2020-08-05
Accepted
2020-08-05 07:15:48
Documents
84
Period of Report
2020-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q eypt-10q_20200630.htm   iXBRL 10-Q 2664201
2 EX-31.1 eypt-ex311_7.htm EX-31.1 15775
3 EX-31.2 eypt-ex312_9.htm EX-31.2 15717
4 EX-32.1 eypt-ex321_6.htm EX-32.1 5536
5 EX-32.2 eypt-ex322_8.htm EX-32.2 5612
  Complete submission text file 0001564590-20-036429.txt   9924539

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA eypt-20200630.xsd EX-101.SCH 76902
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE eypt-20200630_cal.xml EX-101.CAL 54929
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE eypt-20200630_def.xml EX-101.DEF 287192
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE eypt-20200630_lab.xml EX-101.LAB 538171
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE eypt-20200630_pre.xml EX-101.PRE 430145
11 EXTRACTED XBRL INSTANCE DOCUMENT eypt-10q_20200630_htm.xml XML 1871335
Mailing Address 480 PLEASANT STREET SUITE B300 WATERTOWN MA 02472
Business Address 480 PLEASANT STREET SUITE B300 WATERTOWN MA 02472 617-926-5000
EyePoint Pharmaceuticals, Inc. (Filer) CIK: 0001314102 (see all company filings)

IRS No.: 262774444 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-51122 | Film No.: 201075619
SIC: 3826 Laboratory Analytical Instruments